Jamming,
What matters are clinical endpoints. Decreased mortality, avoiding intubation, fewer strokes, etc.
Demonstrating reduced cytokine levels without clinical improvement will not sway the fda (or help patients or Produce sales).
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-